Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes

BMC Pediatrics

Gabriel Q Shaibi¹  Martha Nunez¹  Omar D Hudson² 

[1] College of Nursing and Health Innovation, Arizona State University, 500 N. 3rd St., Phoenix, AZ, 85004, USA;Division of Pediatric Endocrinology and Diabetes, Phoenix Children’s Hospital, Phoenix, AZ, USA

关键词: Aspartate aminotransferase;    Alanine aminotransferase;    Fatty liver;    Type 2 diabetes mellitus;   

Others  :  1170617
DOI  :  10.1186/1471-2431-12-174

 received in 2012-06-28, accepted in 2012-10-25,  发布年份 2012

【 摘 要 】

Background

To examine the influence of ethnicity on liver transaminases among adolescents with type 2 diabetes mellitus (T2DM).

Methods

A retrospective medical chart review of 57 (30 males and 27 females) newly diagnosed patients with T2DM. Ethnicity was determined by self-report and height, weight, body mass index (BMI) and glycosylated hemoglobin (HbA1c) were obtained using standard clinical procedures. Fasting levels of alanine aminotransaminase (ALT) and aspartate aminotransferase (AST) were collected prior to the initiation of any therapy.

Results

Age, gender, height, weight, BMI, and HbA1c did not differ between ethnic groups. Compared to African-Americans, Hispanics had significantly higher ALT (23.9 ± 3.4 vs. 107.8 ± 20.3, p=0.002) and AST (17.7 ± 2.5 vs. 71.1 ± 15.7, p<0.001) and were significantly more likely to have ALT values above the upper limit of normal (20% vs. 71%, p=0.005) and twice the upper limit of normal (0% vs. 39%, p=0.05) as well as AST values above the upper limit of normal (0% vs. 53%, p=0.002). No differences in ALT or AST were found between Hispanics and non-Hispanic whites or between African-Americans and non-Hispanic whites.

Conclusions

These preliminary findings suggest that Hispanic children with T2DM may be at higher risk for developing non-alcoholic fatty liver disease and indicate that a comprehensive hepatic evaluation is warranted in this population. Future studies that incorporate more precise and proximal measures of liver health are warranted in this population.

【 授权许可】

   
2012 Hudson et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM: Prevalence of High Body Mass Index in US Children and Adolescents, 2007–2008. JAMA 2010, 303(3):242-249.
• [2]The Writing Group for the Search for Diabetes in Youth: Incidence of Diabetes in Youth in the United States. JAMA 2007, 297(24):2716-2724.
• [3]Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C: Prevalence of Fatty Liver in Children and Adolescents. Pediatrics 2006, 118(4):1388-1393.
• [4]Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D'Alessio DA: ß-Cell Function, Insulin Sensitivity, and Glucose Tolerance in Obese Diabetic and Nondiabetic Adolescents and Young Adults. J Clin Endocrinol Metab 2006, 91(1):185-191.
• [5]Ciba I, Widhalm K: The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. Acta Paediatr 2007, 96(1):109-112.
• [6]Nadeau KJ, Klingensmith G, Zeitler P: Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 2005, 41(1):94-98.
• [7]Schwimmer JB: Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. Semin Liver Dis 2007, 27(3):312-318.
• [8]Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 1997, 20(7):1183-1197.
• [9]Fraser A, Longnecker MP, Lawlor DA: Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999–2004. Gastroenterology 2007, 133(6):1814-1820.
• [10]Quiros-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW, Butte NF: Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI < or =95th percentile. J Pediatr Gastroenterol Nutr 2007, 44(2):228-236.
• [11]Leung DH, Williams K, Fraley JK, Klish WJ: Age- and ethnic-specific elevation of ALT among obese children at risk for nonalcoholic steatohepatitis (NASH): implications for screening. Clin Pediatr (Phila) 2009, 48(1):50-57.
• [12]Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG: Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 2006, 296(4):421-426.
• [13]Alisi A, Manco M, Panera N, Nobili V: Association between type two diabetes and non-alcoholic fatty liver disease in youth. Ann Hepatol 2009, 8(Suppl 1):S44-S50.
• [14]Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, Esposito A, Scifo P, Ntali G, Costantino F, et al.: Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006, 291(4):E697-E703.
• [15]Goran MI, Bergman RN, Cruz ML, Watanabe R: Insulin resistance and associated compensatory responses in african-american and Hispanic children. Diabetes Care 2002, 25(12):2184-2190.
• [16]Schwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, Schork NJ, Shiehmorteza M, Yokoo T, Chavez A, Middleton MS, et al.: Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009, 136(5):1585-1592.
• [17]Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE: Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005, 115(5):e561-e565.
• [18]Cho NH, Jang HC, Choi SH, Kim HR, Lee HK, Chan JC, Lim S: Abnormal liver function test predicts type 2 diabetes: a community-based prospective study. Diabetes Care 2007, 30(10):2566-2568.
• [19]Wei C, Ford A, Hunt L, Crowne EC, Shield JP: Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic. Arch Dis Child 2011, 96(11):1003-1007.
• [20]Search for Diabetes in Youth Study Group: The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study. Pediatrics 2006, 118(4):1510-1518.
• [21]Pacifico L, Poggiogalle E, Cantisani V, Menichini G, Ricci P, Ferraro F, Chiesa C: Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. World J Hepatol 2010, 2(7):275-288.
• [22]Barlow SE: Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007, 120(Suppl 4):S164-S192.
• [23]Rashid M, Roberts EA: Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000, 30(1):48-53.